Figure 2 | British Journal of Cancer

Figure 2

From: Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells

Figure 2

Effects of cetuximab (100 μg ml−1) alone or combined with cisplatin (1.0, 0.5 and 0.15 μ M for A431, Caski and C33A cells, respectively) and/or RxT (2.0, 1.5 and 0.3 Gy for A431, Caski and C33A cells, respectively) on survival in CA. (A) A431, (B) Caski and (C) C33A cells. (D) Representative picture of A431 cells under different treatments as described in material and methods. One-way analysis of variance (ANOVA) with Tukey's post test *P<0.05, when compared to control cells.

Back to article page